| Factor Information | |
|---|---|
| Data ID | 75 |
| Factor | major visible congenital anomalies |
| Description | Overall, the odds of major visible congenital anomalies in infants born to mothers with ACHD compared with those born to women in the general population were significantly higher (aOR, 1.9; 95%CI, 1.3-2.8), occurring in 1.3%(95%CI, 0.9%-1.9%) of births. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | non-SGA Births |
| p Value | <0.05 |
| OR | 1.9 |
| Conclusion | Certain ACHD subtypes may be associated with increased odds of adverse maternal and neonatal outcomes. It appears from our study that these subtypes should be monitored closely during pregnancy, and prenatal counseling provided to address these risks and any mitigation strategies. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 0 |
| CHD Type | |
| CHD Subtype | |
| Reference | |
|---|---|
| PMID | 31074818 |
| Year | 2019 |
| Title | Association of Adult Congenital Heart Disease With Pregnancy, Maternal, and Neonatal Outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults (women) | |
| Source | Discharge Abstract Database | |
| Region | all hospitalizations in Canada (except Quebec), Canada | |
| Method | cross-sectional study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | all infants of women with any type of ACHD(Treatment) | all infants of women without ACHD(Control) |
| Number | 27 (total: 2114) | 17197 (total: 2682451) |
| Age | 29.4±5.7 (M±SD) | 29.8±5.6 (M±SD) |
| Gender (Male: Female) | 0:27 | 0:17197 |
| Marker Level | 0.013 | 0.006 |
